Peripheral facial paralysis: Aetiology, diagnosis and treatment;Paralisis facial periferica: Etiologia, diagnostico y tratamiento

Revista de Neurologia

Volumn 30, Issue 11, 2000, Pages 1048-1053

  Santos Lasaosa, S ^a   Pascual Millan L F ^a   Tejero Juste, C ^a   Morales Asin F ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Aetiology; Bell's palsy; Diagnosis; Peripheral facial paralysis; Prognosis; Treatment

Indexed keywords

ACICLOVIR; GANGLIOSIDE; PREDNISONE; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT;

BELL PALSY; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAM; ELECTRONEUROGRAPHY; EYELID REFLEX; FACIAL NERVE PARALYSIS; FOLLOW UP; HUMAN; NEUROPHYSIOLOGY; PROGNOSIS; REVIEW; SYMPTOM; DRUG ADMINISTRATION; DRUG COMBINATION; ELECTROMYOGRAPHY; METHODOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE;

ACYCLOVIR; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ELECTROMYOGRAPHY; FACIAL PARALYSIS; FOLLOW-UP STUDIES; HUMANS; PERIPHERAL NERVES; PREDNISONE;

EID: 0034202688     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3011.99618     Document Type: Review

References (25)

1. Bell C. The nervous system of the human body (appendix; case 49). London: Longman, Rees, Orme, Brown & Green; 1830. p. 85-7.
2. Peitersen E. The natural history of Bell's palsy. Am J Otol 1982; 4: 107-11.
3. Adour KK. Current concepts in neurology: diagnosis and management of facial palsy. N Engl J Med 1982; 307: 348-51.
4. Roob G, Facekas F, Hartung HP. Parálisis facial periférica: etiología, diagnóstico y tratamiento. Eur Neurol 1999; 4: 173-9. (Edición española).
5. Williamson IG, Whelan TR. The clinical problem of Bell's palsy: is treatment with steroids effective? Br J Gen Pract 1996; 46: 743-7.
6. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell's palsy and herpes simplex virus: identification of viral DNA in endoneural fluid and muscle. Ann Intern Med 1996; 124: 27-30.
7. Neau JP, Rosplacci T, Pin JC, Gil R. Paralysies faciales périphériques idiopathiques. Valeur pronostique de l'étude conjointe du réflexe de clignement et de la stimulodétection du nerf facial: À propos de 92 cas. Neurophysiol Clin 1992; 22: 465-73.
8. Fernández JM, Mederer S, Battle J, Pardo J, Torres M. Evaluación neurofisiológica de la parálisis facial periférica y tendencias actuales en su tratamiento. Rahabilitacion 1993; 27: 35-43.
9. Gante BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell's palsy. Laryngoscope 1999; 109: 1177-88.
10. Prim MP, De Diego JI, Sanz O. Prognostic factors in patients with idiopathic facial paralysis (Bell's palsy): a prospective study. ORL J Otorhinolaryngol Relat Spec 1999; 61: 212-4.
11. Taverner D. Cortisone treatment of Bell's palsy. Lancet 1954; ii: 1052-4.
12. Burgess LPA, Yim DWS, Lepose ML. Bell's palsy: The steroid controversy revisited. Laryngoscope 1984; 94: 1472-6.
13. May M, Wette R, Hardin WB, Sullivan J. The use of steroids in Bell's palsy: a prospective controlled study. Laryngoscope 1976; 86: 1111-2.
14. Wolf SM, Wagner JH, Davidson S, Forsythe A. Treatment of Bell's palsy with prednisolone: a prospective randomized study. Neurology 1978; 28: 158-61.
15. Austin JR, Peskind SP, Austin SG, Rice DH. Idiopathic facial nerve paralysis: a randomized double blind controlled study of placebo versus prednisolone. Laryngoscope 1993; 103: 1326-33.
16. De Diego Sastre JI, Prim Espada MP. Utilización del aciclovir en la parálisis facial aguda periférica idiopática (de Bell). Acta Otorrinolaringol Esp 1999; 50: 121-4.
17. Ibarrondo J, Navarrete ML, Encarnación LF, Quesada P, Crespo F, García M, et al. Tratamiento de la parálisis facial idiopática: corticoides versus aciclovir versus empírico. Acta Otorrinolaringol Esp 1999; 50: 118-20.
18. De Diego JI, Prim MP, Sarria MJ, Madero R, Gavilán J. Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope 1998; 108: 573-5.
19. Adour KK, Ruboylanes JM, Von Doersten PG, Byl FM, Trent CS, Quesenberry CP Jr, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105: 371-8.
20. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandai BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900.
21. Mezzina C, De Grandis D, Calvani M, Marchionni A, Pomes A. Idiopathic facial paralysis: new therapeutic prospects with acetyl-carnitine. Int J Clin Pharmacol Res 1992; 12: 299-304.
22. Negrin P, Fardin P. Effect of cerebral cortex gangliosides on the clinical electromyographic evolution of 'a frigore' facial paralysis. A propose of 24 cases. Minerva Med 1978; 69: 3277-82.
23. Yaya R, Lago A, Moral A, Sevilla MT, Piqueras A. Gangliosides in the treatment of idiopathic facial paralysis (Bell's palsy). Curr Ther Res 1986; 40: 29-34.
24. Bigland AW, May M, Bowers RA. Management of facial spasm with clostridium botulinum toxin type A (oculinum). Arch Otolaryngol 1988; 114: 1407-12.
25. López del Val JL, Morales Asín F. Nuevas aplicaciones de la toxina botulínica. Neurologia 1998; 13: 388-94.